Camber Launches Magnesium Sulfate Injection
Camber, a leader in generic drug approvals and launches, is proud to add Magnesium Sulfate Injection, USP [mag-NEE-see-um-SUL-fate] to its growing portfolio.
Magnesium Sulfate Injection, USP is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.
Magnesium Sulfate Injection, USP is available in:
| Strength | Size |
| 1g / 2mL (500mg per mL) * | 25 x 2 mL Single-Dose Vials |
| 5g / 10mL (500mg per mL) | 25 x 10 mL Single-Dose Vials |
| 10g / 20mL (500mg per mL) | 25 x 20 mL Single-Dose Vials |
| 25g / 50mL (500mg per mL) * | 25 x 50 mL Single-Dose Vials |
*Camber Pharmaceuticals has 180-day exclusivity on 1g / 2mL (500mg per mL) and 25g / 50mL (500mg per mL).
To learn more about this product, visit: www.camberpharma.com/magnesium-sulfate
Recent articles
- New to Camber’s Portfolio: Olmesartan medoxomil, Amlodipine and Hydrochlorothiazide Tablets
- Camber Pharmaceuticals Honored as Second Merit Finalist at 2026 DIANA Awards
- Camber Launches Nitazoxanide Tablets
- Cisatracurium Besylate Injection, USP Added to Camber’s Portfolio
- Camber Welcomes Summer 2026 Intern Class
- Camber Launches 5 Generics in May






